Eli Lilly’s Potential One-Two Punch for Zyprexa Users
Talk about ironies. more…
Talk about ironies. more…
Eli Lilly and its Zyprexa legal woes have hit the road. more…
Microsoft’s proposed $45 billion bid for Yahoo has received some well-deserved critical coverage. more…
One of the silver linings (no pun intended) of turning 50 was, I thought, becoming eligible for membership in the AARP. more…
After months of trumpeting the Starwood Preferred Guest program and mere hours after reaffirming my preference for its Westin Hotels chain, I regrettably find myself doing a complete 180 as I declare a personal boycott of all Starwood properties. more…
With the snow piling up outside my office window and the ice and slush taking over midtown’s sidewalks 23 stories below, can you fault me for having California on my mind? more…
Related post about Toni Locy and the federal shield law.
Compared to their brethren in other countries, U.S.-based reporters enjoy unparalleled power and constitutional protection. more…
Let’s face it, most airlines are indifferent about public relations. more…
It looks like we got spun again by The New York Times. more…
Update: Alex Berenson admits some truth on NPR and The New York Times‘ comments had an element of spin. more…